Articles with "janssen scientific" as a keyword



Photo by cdc from unsplash

E088 Safety of guselkumab in patients with psoriatic disease: an integrated analysis of 11 Phase 2 and 3 clinical studies in psoriasis and psoriatic arthritis

Sign Up to like & get
recommendations!
Published in 2023 at "Rheumatology"

DOI: 10.1093/rheumatology/kead104.337

Abstract: Guselkumab is a monoclonal antibody approved to treat moderate-to-severe plaque psoriasis and active psoriatic arthritis (PsA). In this analysis, safety data from 11 Phase 2/3 studies of guselkumab were pooled to evaluate guselkumab safety in… read more here.

Keywords: scientific affairs; johnson johnson; johnson; janssen scientific ... See more keywords
Photo by taylorkeeran from unsplash

SAT0175 A descriptive analysis of real-world treatment patterns in a turkish rheumatology population that continued innovator infliximab (REMICADE) therapy or switched to biosimilar infliximab

Sign Up to like & get
recommendations!
Published in 2017 at "Annals of the Rheumatic Diseases"

DOI: 10.1136/annrheumdis-2017-eular.1128

Abstract: Objectives This study examined treatment patterns in a rheumatology patient (pt) population initially prescribed innovator infliximab (IFX) that either switched to biosimilar infliximab (CT-P13) or continued on IFX following availability of CT-P13 in the Turkish… read more here.

Keywords: infliximab; affairs llc; janssen scientific; scientific affairs ... See more keywords
Photo by schluditsch from unsplash

Real-World Comparative Effectiveness, Treatment Patterns, and Costs in Type 2 Diabetes Mellitus (T2DM) Patients Initiated on Canagliflozin 300 mg (CANA) or a Glucagon-Like Peptide-1 Receptor Agonist (GLP-1)

Sign Up to like & get
recommendations!
Published in 2018 at "Diabetes"

DOI: 10.2337/db18-1287-p

Abstract: This study compared HbA1c control, treatment patterns, and costs in adults with T2DM initiated on CANA or a GLP-1 based on administrative claims data from the HealthCore Integrated Research Database (4/2013-02/2016) augmented with laboratory data.… read more here.

Keywords: treatment; affairs llc; self janssen; janssen scientific ... See more keywords
Photo from archive.org

1517-P: Characteristics and Burden of Macro, Micro, and Normoalbuminuria in Patients with Type 2 Diabetes (T2D)

Sign Up to like & get
recommendations!
Published in 2020 at "Diabetes"

DOI: 10.2337/db20-1517-p

Abstract: Individuals with T2D and diabetic nephropathy are at higher risk for adverse cardiovascular events. This study compared patient characteristics and disease burden by severity of albuminuria (normoalbuminuria [NOR], microalbuminuria [MIU], macroalbuminuria [MAU]) among T2D patients… read more here.

Keywords: affairs llc; self janssen; janssen scientific; scientific affairs ... See more keywords